Forbes on Instagram: ""75% of patients have not achieved their target serum phosphate levels." Why? According to Dr. Shalabh Gupta, Founder, Chairman & CEO of Unicycive Therapeutics, the "pill burden" from complex regimens is a major roadblock for patients and doctors. He shared this critical insight at the 2025 Forbes Healthcare Summit, detailing how Unicycive is driving innovation to create a streamlined solution. Presented by @unicycive⁣ ⁣ Learn More: https://bit.ly/4p9AEya"